Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TECOGEN INC. Director's Dealing 2023

Mar 27, 2023

33623_dirs_2023-03-27_583a7536-a805-40a0-99f6-9d3107c71004.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECOGEN INC. (TGEN)
CIK: 0001537435
Period of Report: 2023-03-20

Reporting Person: Rangesh Abinand (Director, Chief Executive Officer, Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-20 Common Stock P 800 $0.8452 Acquired 6800 Direct
2023-03-20 Common Stock P 1000 $0.8995 Acquired 7800 Direct